Results for this period
Interim period (second quarter)2025年4月1日〜2025年9月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
車載用等コンデンサ向け導電性高分子薬剤の販売が伸長したものの、微粒子製品を中心に機能性材料事業が低調であった。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年4月1日〜2025年9月30日 |
| Net Sales | ¥27,056 million (YoY -3.2%) |
| Operating profit | ¥1,407 million (YoY -35.6%) |
| Ordinary income | ¥1,561 million (YoY -30.1%) |
| Profit attributable to owners of the parent | ¥1,047 million (YoY -28.7%) |
| Net income per share | 45円88銭 |
| Equity ratio | End of the current fiscal period 67.3 / End of previous period 66.6 |
| Total assets | ¥90,175 million |
| Net assets | ¥61,249 million |
| Cash flows from operating activities | ¥1,800 million |
| Cash flows from investing activities | ¥-3,884 million |
| Cash flows from financing activities | ¥-66 million |
| Cash and cash equivalents at end of period | ¥11,719 million |
| Full-year earnings forecast | Net Sales ¥59,000 million (YoY +5.9%) / Operating profit ¥3,300 million (YoY -6.4%) / Ordinary income ¥3,600 million (YoY -3.9%) / Net income ¥2,400 million (YoY -0.9%) |
| Annual Dividend Forecast | ¥38 → ¥40 |
| Segment revenue | Functional Materials Business ¥13,173 million (YoY -11.0%), Electronic materials and chemicals business ¥13,316 million (YoY +5.7%), Other ¥566 million (YoY +1.3%) |
| Segment profit | Functional Materials Business ¥94 million, Electronic materials and chemicals business ¥1,193 million, Other ¥115 million |
| Depreciation and amortization | ¥1,513 million |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥2 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥44 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 23,914,414 Shares |
| Treasury Shares at Period-End | 1,083,426 Shares |
| Factors Behind Changes in Business Performance | 車載用等コンデンサ向け導電性高分子薬剤の販売が伸長したものの、微粒子製品を中心に機能性材料事業が低調であった。 |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.車載用等コンデンサ向け導電性高分子薬剤の販売が伸長したものの、微粒子製品を中心に機能性材料事業が低調であったため。機能性材料事業では建築塗料用途や海外向け、大手化粧品メーカー向けの販売が低調に推移した。